JPRN-UMIN000012975招募中未知
A I/II phase study of chemotherapy using irinotecan plus L-OHP plus S-1 treatment (SOXIRI) for unresectable advanced pancreatic cancer - A phase I/II study of chemotherapy(SOXIRI)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) infusion of blood products within 7days (2) not first line treatment (3) severe Allergie (4) much ascites or pleural effusion (5) infection (6) diarrea (7) ileus (8) neuropathy (9) severe heart disorder (10) neuropsychiatric disorder (11) idiopathic pulmonary fibrosis or Idiopathic interstitial pneumonia (12) brain metastasis (13) pregnancy case (14) unsuitable case
研究者
相似试验
已完成
1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancerJPRN-UMIN000016945Department of Gastroenterology Kitasato University School of Medicine25
已完成
1 期
Phase I study of combination chemotherapy with irinotecan hydrochroride(CPT-11) and nedaplatin(NDP) for locally advanced stage Ib2-IVa cervical cancer after Concurrent chemoradiotherapy (CCRT)Stage Ib2-IVa cervical cancerJPRN-UMIN000007458Japanese Gynecologic Oncology Group48
已完成
2 期
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancerStage lb2 lla cervical cancer with pelvic lymph node metastasisJPRN-UMIN000003036Japanese Gynecologic Oncology Group63
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
已完成
不适用
Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors.Gynecologic cancerJPRN-UMIN000013951Department of Obstetrics and Gynecology, Hyogo College of Medicine16